Regeneron falls over 4% ahead of lower drug prices expectations

Friday, 24. July 2020 17:57

Regeneron stock fell on Friday by more than 4% ahead of the United States President Donald Trump’s executive orders aimed at lowering drug prices.

Trump is expected to sign a series of executive orders regarding the cutting of Medicare’s drug prices in order to ensure that the US doesn’t pay more than other countries. The drug discount program dubbed 340B would give hospitals access to drugs at the discounted prices.

At 11:48 am ET the stock price fell by 4.10% selling for $604.65.

Related Links: Regeneron Pharmaceuticals Inc.
Breaking the News / TF